Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
Articles by Ana de Barros
Recent Posts
- Trial will test gene therapy for limb-girdle muscular dystrophy type
- Having the support of friends, old and new, makes all the difference
- Mitochondrial dysfunction may be a treatment target in DM2
- FDA approves oral givinostat, as Duvyzat, to treat Duchenne MD
- Duchenne clinical trials show me how mature my sons have become
- Givinostat slows motor function loss in boys with DMD in trial: Results
- Agamree, next-gen steroid, now available for DMD patients in US
- 7 tips for traveling alone with my 3 sons who have Duchenne
- MDA 2024: Limb, heart function preserved with DMD cell therapy
- Turning to prayer when thoughts of uselessness creep in